News & Events about Celanese Corporation.
Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced that it has entered into an agreement with Glaukos Corporation to supply its VitalDose Drug Delivery Platform for use as a component in Glaukos iDose TR, a micro-invasive intraocular implant designed...
Fiduciary Trust Co. boosted its stake in Celanese Co. (NYSE:CE Get Rating) by 88.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,817 shares of the basic materials companys stock after ...
Business Wire
3 months ago
Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, today announced an agreement with Johns Hopkins University Department of Ophthalmology to collaborate on a study of sustained drug delivery to the suprachoroidal space in the eye. Direct administration of...
Business Wire
3 months ago
Celanese Corporation (NYSE: CE), a global specialty materials and chemical company, announced the availability of more sustainable versions of multiple Acetyl Chain materials with mass balance bio-content. These offerings will be designated as ECO-B, consistent with the innovative bio-based...
Ticker Report
6 months ago
CI Investments Inc. reduced its stake in Celanese Co. (NYSE:CE Get Rating) by 43.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 621 shares of the basic materials companys stock after selling 476...